At HLG, we have given close attention during the past year to the regulatory challenges faced by compounding pharmacies in this new era of FDA oversight. However, in recent weeks, it has become starkly evident that compounding pharmacists are, also, squarely in the prosecutorial sights of the DOJ. At HLG, our professional focus is on legal representation in business litigation and administrative proceedings, such as FDA inspections. However, we also have years of experience in the defense of parties charged with business-related crimes. For this reason, our most recent postings have discussed what we believe to be a dramatic uptick in prosecutorial activity directed at compounding pharmacies. (more…)
In the last days of June, the final chapter of the New England Compounding Pharmacy (NECP) story unfolded in the Boston federal courtroom of Judge Richard G. Stearns. Barry J. Cadden, the head pharmacist and former co-owner of NECP was sentenced to nine (9) years in federal prison. As we previously reported on this website, Cadden was convicted earlier this spring on federal fraud and racketeering charges arising from an outbreak of fungal meningitis and related infections, which has been described as among the worst recent public health crises in the United States. (more…)
When a real estate business ended with a fight over a trophy property in an upscale Atlanta location, the minority stakeholder hired the Hasson Law Group to represent his financial interests. Going up against a large international firm, managing partner Keith S. Hasson successfully appealed a summary judgment that had limited his client’s proceeds from the property’s sale and counterclaims for breach of contract and fiduciary duty. As an indication that Hasson’s argument was precisely framed, the appeals court reversed the summary judgment quickly.
For the twenty-third year, during the early summer months, the International Academy of Compounding Pharmacists (IACP) held its Compounders on Capitol Hill meeting in Washington, D.C. from June 10-13, 2017. Keith S. Hasson, founder of the Hasson Law Group, attended the meeting as the guest of two of his long-time clients in the compounding industry. During and after the meeting, Keith has reviewed and discussed with IACP members two dramatic legislative changes that deserve the support of compounders throughout the Nation. The legislation was introduced, and all compounding pharmacists in Georgia and around the country need to review it and, hopefully, get busy supporting it. (more…)
Keith Hasson authored an article published by Law360 on March 28, 2017, discussing the ongoing regulatory updates compounding pharmacies must monitor, including changes in the U.S. Food and Drug Administration (FDA) inspection methods and the proposed rule adding new bulk substances that can be used in compounding.